Tenofovir DF, emtricitabine, and efavirenz vs. zidovudine, lamivudine, and efavirenz for HIV
Article Abstract:
A prospective, randomized, multicenter noninferiority study comparing the regiments of tenofovir DF, emtricitabine and efavirenz and a fixed dose of zidovudine and lamivudine plus efavirenz were conducted. Results revealed that the combination of tenofovir DF and emtricitabine plus efavirenz fulfilled the criteria for noninferiority to a fixed dose of zidovudine and lamivudine plus efavirenz and proved superior in terms of virologic suppression, CD4 response, and adverse events resulting in discontinuation of the study drugs.
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 2006
User Contributions:
Comment about this article or add new information about this topic:
Efficacy and safety of tenofovir DF vs. stavudine in combination therapy in antiretroviral-naive patients
Article Abstract:
Tenofovir disoproxil fumarate (DF) is the first nucleotide analog reverse transcriptase inhibitor approved for treatment of human immunodeficiency virus (HIV) and a test was conducted to assess its efficacy and safety compared with stavudine in antiretroviral-naive patients. It was found, over a period 144 weeks, that combination of tenofovir DF, lamivudine and efavirenz was highly effective and also comparable with a combination of stavudine, lamivudine and efavirenz in antiretroviral-naive patients.
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 2004
User Contributions:
Comment about this article or add new information about this topic:
Efficacy and safety of Emtricitabine vs. Stavudine in combination therapy in antiretroviral-naive patients
Article Abstract:
A test was conducted to assess the efficacy and safety of emtricitabine as compared to stavudine in combination with didanosine and efavirenz. It was found that drug, emtricitabine administered once daily showed greater virological efficacy, steady response and tolerability as compared to stavudine administered twice daily combined with didanosine and efavirenz.
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 2004
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy
- Abstracts: Nulliparous active labor, epidural analgesia, and cesarean delivery for dystocia. Brachial plexus injury: A 23-year experience from a tertiary center
- Abstracts: Coffee, CYP1A2 genotype, and risk of myocardial infarction. Duration of lactation and incidence of type 2 diabetes
- Abstracts: Beyond the pill: New data and options in hormonal and intrauterine conception
- Abstracts: A randomized controlled trial of an HIV sexual risk-reduction intervention for young African-American women. Efficacy of an HIV prevention intervention for African-American adolescent girls